Safety and Efficacy of Pembrolizumab in Combination with Bevacizumab + CapeOX in the Neoadjuvant Treatment of RAS-mutated, BRAF Wild-type, Microsatellite-stabilized, Locally Advanced Colorectal Cancer
Clinical trial NCT06550453 · RECRUITING
Trial details
- NCT number
- NCT06550453
- Sponsor
- yangjianjun
- Status
- RECRUITING
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2024-09-01
- Primary completion
- 2025-01-15
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.